# Progress Note 05 — Focused Visit (Care-plan review)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Florence Nightingale (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI004-SYN-TD
- Date: 1858-09-14
- Fictional facility: St. Posthumous Health Center
- Fictional author: Isobel Marchetti, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Focused Visit (Care-plan review)

## Chief complaint

Six-month ME/CFS care plan review. **S**

## History of present illness

Ms. Nightingale returns for her six-month review. The extra half hour of work agreed in June held without post-exertional malaise, and she later added another half hour, so she now works four to five hours a day in 45-minute blocks with rests between. Her July cold caused a flare that settled in about ten days on her flare plan, with no fever afterward and no night sweats or back or joint pain. Since then she has had no crash. She goes out twice a week, for a short walk or a meeting, and plans a rest day after each outing. She is lightheaded on standing about twice a week. Sleep is still not fully refreshing, and acetaminophen is needed a few times a month. She takes cholecalciferol daily. **S**

| Element | Detail |
|---|---|
| Interval change | One flare after a cold in July; no crash since |
| Energy management | Four to five hours of work a day in 45-minute blocks |
| Function | Out of the house twice a week with a rest day after |
| Orthostatic symptoms | About twice a week |
| Infection warning signs | No fever, night sweats, or back or joint pain since the cold |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Fatigue at an improved baseline; no fever, night sweats, or weight loss |
| Cardiovascular | Positive | Lightheaded on standing about twice a week; no syncope |
| Musculoskeletal | Negative | No back, hip, or joint pain or swelling |
| Neurological | Positive | Word-finding difficulty only when tired |
| Psychiatric | Negative | Mood steady; PHQ-9 score 5 and GAD-7 score 4 |

5 systems reviewed. **S**

## Current medications

- Acetaminophen 500 mg oral tablet, one to two tablets by mouth every 6 hours as needed for muscle pain or headache, no more than 3 g a day **S**
- Cholecalciferol (vitamin D3) 50 mcg (2,000 units) oral tablet, one tablet by mouth daily **S**

## Allergies

- No known allergy **S**

## Objective

BP 108/70 mmHg; pulse 72 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 99% on room air; weight 56 kg; BMI 19.4 kg/m². All vital signs are synthetic.

25-hydroxyvitamin D: 34 ng/mL; PHQ-9: 5; GAD-7: 4; PROMIS fatigue T-score: 64; PROMIS physical function T-score: 38; Pain score (0 to 10): 3. All results are synthetic.

## Change since baseline

- 25-hydroxyvitamin D: 17 ng/mL (low) at baseline, 34 ng/mL at this visit **S**
- PHQ-9: 8 at baseline, 5 at this visit **S**
- GAD-7: 5 at baseline, 4 at this visit **S**
- PROMIS fatigue T-score: 71 at baseline, 64 at this visit **S**
- PROMIS physical function T-score: 32 at baseline, 38 at this visit **S**
- Pain score (0 to 10): 4 at baseline, 3 at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well and engaged throughout the visit |
| Cardiovascular | Regular rhythm; no murmur |
| Abdomen | No liver or spleen enlargement |
| Musculoskeletal | No spinal, sacroiliac, or joint tenderness |
| Orthostatic test | Ten-minute standing test: heart rate rise of 18/min, down from 26/min at intake; no hypotension; mild lightheadedness only after minute 8 |

All examination findings are synthetic. **S**

## Assessment and plan

1. **ME/CFS, moderate, improving** (G93.32). Stable on her energy management plan with more working time and no crash since the July flare. PROMIS fatigue 64 (from 71 at intake) and physical function 38 (from 32); pain score 3. Orthostatic intolerance has improved on the standing test. **S**
   - Continue the energy management plan; any further increase only in small steps she chooses, guided by the diary.
   - Continue fluids, salt, and compression.
   - Next care plan review in about three months, and at least yearly after that.
2. **Vitamin D deficiency, replete** (E55.9). 25-hydroxyvitamin D 34 ng/mL. **S**
   - Continue cholecalciferol 2,000 units daily.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Laboratory | 25-hydroxyvitamin D after starting repletion | Once, about three months after starting | Completed today | 34 ng/mL, now replete; drawn today after it was missed at the three-month review |
| Survey | PHQ-9 and GAD-7 | At diagnosis and at each review | Completed today | PHQ-9 5 with item 9 scored 0; GAD-7 4 |
| Survey | PROMIS fatigue and physical function T-scores, pain score | At diagnosis and at each review | Completed today | Fatigue 64, physical function 38, pain 3 |
| Examination | Ten-minute standing test | Repeat at six months | Completed today | Heart rate rise of 18/min, down from 26/min |
| Examination | Symptom review, including infection warning signs | Every review | Completed today | No crash since the July flare; no fever, night sweats, or focal pain |
| Self-management | Energy management and flare plan review | Every review | Completed today | Flare plan worked as intended during the July cold |
| Medication safety | Medication review | Every review | Completed today | Cholecalciferol daily; acetaminophen a few times a month |
| Referral | ME/CFS specialist team | At diagnosis (NICE 1.4.3) | Deferred | Still no regional service; care continues in primary care with the occupational therapist available as needed |

## Goal progress

- Agree an energy management plan with a stable baseline and no more than one crash a month by the six-month review. Outcome by 1858-09-14: One flare in three months, after a cold; no crash from overexertion since the summer. **S**
- Keep working within her energy limits, aiming for four hours a day in planned blocks by the six-month review. Outcome by 1858-09-14: Working four to five hours a day in 45-minute blocks with rest between. **S**
- Fewer orthostatic symptoms with fluids, salt, compression, and seated or reclined tasks by the three-month review. Outcome by 1858-06-01: Lightheaded on standing two or three times a week instead of daily. **S**
- Replete vitamin D to 30 ng/mL or higher. Outcome by 1858-09-14: 25-hydroxyvitamin D 34 ng/mL. **S**

## Guideline basis

- Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management (NICE guideline NG206) (2021), National Institute for Health and Care Excellence
- Diagnosing ME/CFS (2024), Centers for Disease Control and Prevention
- Grach SL, et al. Diagnosis and Management of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Mayo Clin Proc 2023;98(10):1544-1551 (2023), Mayo Clinic Proceedings

## Follow-up

- Adult preventive visit next month. ME/CFS review in about three months, then at least yearly. **S**
- Next scheduled visit 1858-10-12: adult preventive visit. **S**
